Oncology Perspective

• Alcohol, Melatonin, and Other Top Clinical Topics of 2022 See which studies led to the most popular clinical topics of the year, with an infographic on each of the key findings.
  Medscape, November 28, 2022
• 20 Best Holiday Gift Ideas for Doctors It's holiday season. Here are some great and innovative suggestions for finding that perfect gift for the physician in your life.
  Medscape Features Slideshows, November 23, 2022
• Cancer Prevention and Treatment in Europe vs. the U.S.   Fabrice Barlesi, MD, PhD, general director of Institut Gustave Roussy, one of the world's leading cancer centers, discusses Europe's approach to cancer treatment and prevention.
  WebMD, November 23, 2022
• 20 Best Holiday Gift Ideas for Nurses From pampering their hands and feet to sanitizing and tracking their gadgets, Medscape offers suggestions for presents for the nurse in your life.
  Medscape Features Slideshows, November 22, 2022
• A Medically Tailored Holiday Meal Providers of food as medicine to patients with chronic diseases across the United States share their favorite healthy recipes, which can be downloaded and printed.
  Medscape Family Medicine, November 21, 2022
• Much-Needed Guidance Arrives on Drug-Induced Liver Injury Dr Nancy Reau speaks with Dr Robert Fontana, the co-author of recent guidance from the AASLD on how to diagnose and manage the harmful consequences of certain drugs and unregulated supplements.
  Medscape Gastroenterology, November 21, 2022
• CLL e-Tumor Boards: Case 2: Relapsed Chronic Lymphocytic Leukemia   This case focuses on a woman who was diagnosed with CLL in her late 50s. She was initially observed for one year and received treatment with a chemoimmunotherapy combination. She relapsed twice before. Now in her 70s, she presents to the team with progressive disease and is seeking new treatment options.
  Medscape, November 21, 2022
• Discontinuing Immunotherapy: Half Empty or Half Full? Thoracic oncologist Jack West discusses the nuances of discontinuing immunotherapy in patients with NSCLC with a positive response at 2 years.
  Medscape Oncology, November 21, 2022
• 25 Terrific Winter Vacations for Doctors From sun-drenched beaches to powdery ski slopes and vibrant cities, these 25 destinations in the US and abroad have much to offer stressed-out physicians seeking a break.
  Medscape Features Slideshows, November 18, 2022
• Why Is the FDA Granting Regular Approvals Prematurely? Oncologist Bishal Gyawali discusses how the number of drugs being given full FDA approval based on surrogate endpoints is on the rise.
  Medscape Oncology, November 18, 2022
• More Telehealth Training Needed in Medical Education The sudden growth of telemedicine during the pandemic created a desire for clinicians and hospital systems to improve their skills in the virtual realm.
  Medscape Business of Medicine, November 18, 2022
• Discerning Bias in Cancer News Oncologist Jack West critiques medical journalism written without balance and rigor, either accidentally or not.
  Medscape Oncology, November 17, 2022
• Post-Roe v Wade: Its Impact on Many Medical Specialties   Art Caplan, PhD, discusses how the overturn of Roe v Wade has implications for all manner of medical practice.
  Medscape Business of Medicine, November 16, 2022
• How Would You Treat Your Spouse? Practical but Not Hard Evidence Most cancer patients are looking for a recommendation based on insight, not clinical trial statistics, oncologist Jack West argues.
  Medscape Oncology, November 16, 2022
• Episode 5: Small Cell Lung Cancer Treatment Options   Drs Jacob Sands and Lauren Byers discuss the treatment options for patients diagnosed with small cell lung cancer and the future possibility of durable responses.
  Medscape, November 15, 2022
• Love Them or Hate Them, Masks in Schools Work   F. Perry Wilson, MD, MSCE, Associate Professor, Department of Medicine, Yale School of Medicine; Director, Clinical and Translational Research Accelerator, Yale School of Medicine, New Haven, Connecticut
  Medscape, November 14, 2022
• Early Breast Cancer e-Tumor Boards: Case 2: HER2-positive De Novo Metastatic Breast Cancer   This case is about a 46-year-old premenopausal patient with HR+/HER2+ de novo metastatic breast cancer. She was referred to the tumor board after a mass reappeared in her right breast. The team discusses the best approach to oligoprogression in breast cancer patients, including genetic testing, surgery, and second-line treatment.
  Medscape, November 14, 2022
• ADCs for Breast Cancer: 5 Things to Know Recent therapeutic advances in ADCs offer new options that are reshaping the treatment landscape in controlling breast cancer. Learn more about five key aspects of these groundbreaking therapies.
  Medscape Oncology, November 11, 2022
• Medical Software Templates: Use at Your Own Peril Neurologist Allan Block warns that "regardless of how harmless and unintentional it might be," medical templates' default settings can annoy patients and other offices and should be monitored.
  MDedge, November 10, 2022
• Infographic: The Good and Bad of Self-employment as a Doctor Physicians who typically are owners in a solo or group practice or partners reveal the five aspects of self-employment they enjoy the most, and five they like the least.
  Medscape, November 10, 2022